iCAD Inc (ICAD)

[dletizia]

?

Google Health Launches AI Partnership to Improve Breast Cancer Screening

Google Health has launched its first commercial agreement to license its mammography AI research model for integration into real-world clinical practice.

??

By Shania Kennedy on November 29, 2022

Google Health and mammography artificial intelligence (AI) vendor iCAD, Inc. announced a strategic partnership to integrate Google Health’s AI technology into iCAD’s portfolio of breast imaging AI solutions in an effort to improve breast cancer detection and assessment of short-term personal cancer risk.

This partnership is the first time Google Health has licensed its mammography research model, and according to a press release shared following Google’s announcement, iCAD will work toward validating and incorporating the tech giant’s mammography AI technology into its product portfolio for use in clinical practices. The two companies said they will also work together to enhance breast cancer AI solutions for mammography and expand access to these tools to millions of patients and providers worldwide.

RELATED ARTICLES

Hackensack Meridian Health to Leverage Google's New Medical Imaging Tool

Harvard, Stanford Develop Self-Supervised AI to Detect Disease Via X-ray

Geisinger Deploys AI Imaging Model to Diagnose Coronary Artery Disease

Sign up for our newsletter!

“Google Health is our cross-company initiative to use technology to help everyone, everywhere be healthier – and collaborating with leading-edge companies like iCAD is a key part of this strategy,” said Greg Corrado, PhD, Head of Health AI at Google, in the press release.

Under the collaboration, Google and iCAD will focus on advancing innovation and expanding access to mammography technology via cloud-based solutions, the press release states. Google Health’s AI technology is set to be integrated into iCAD’s Breast AI Suite, a portfolio of technologies for breast cancer detection, density assessment, and personalized short-term risk evaluation. By validating and integrating Google’s mammography tools into this portfolio, the agreement aims to support cancer patients’ journeys, the companies said.

iCAD is also set to incorporate Google’s mammography AI offerings into ProFound AI Risk, a clinical decision support tool designed to provide an accurate, personalized short-term breast cancer risk estimation. Using Google’s solutions, iCAD said it hopes to improve the performance of its algorithms for 2D and 3D mammography.

In addition to leveraging Google’s AI technology, iCAD will also use Google Cloud’s infrastructure to expand cloud-hosted mammography solutions into new regions and scale access to these tools in underserved areas, according to Google’s announcement.

“Healthcare providers are increasingly moving away from locally deployed systems in favor of virtual or remote settings,” said Stacey Stevens, president and CEO of iCAD, in the press release. “Additionally, hospitals are under increasing pressure to reduce costs, while providing higher quality care, underscoring the need to streamline operations and increase clinician productivity. Integrating Google’s Cloud technology into this more flexible delivery model offers facilities the solution they need, and the technology patients deserve.”

The partnership is also set to build on Google Health’s work in mammography.

In 2020, Google published research showcasing how one of its AI models was able to identify breast cancer in screening mammograms with greater accuracy, fewer false positives, and fewer false negatives than radiologists.

Using de-identified mammograms from over 3,000 patients in the US and 25,000 in the UK, the AI model produced a 5.7 percent reduction of false positives in the US, and a 1.2 reduction in the UK. The model also produced a 9.4 percent reduction in false negatives in the US and a 2.7 percent reduction in the UK.

Tagged Artificial Intelligence,  Cancer Detection,  Google,  Imaging Analytics,  Medical Imaging

Dig Deeper

Google Uses Artificial Intelligence to Detect Breast Cancer

Deep Learning Predicts Women’s Future Risk of Breast Cancer

Google Deep Learning Tool 99% Accurate at Breast Cancer Detection

Related Resources

Taking Control of ED Processes to Reduce Costs and Improve Patient Satisfaction

Chronic Disease Care: Essential AI for Health Plans

View on HealthITAnalytics

©2012-2022 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthITAnalytics.com is published by Xtelligent Healthcare Media a division of TechTarget.

[Netcool]

Go $iCAD https://seekingalpha.com/news/3911558-icad-stock-jumps-after-licensing-deal-with-google-for-breast-cancer-imaging

[Netcool]

Hopefully this subscription model is a success but may take a few quarters to show the street something. Is there a white knight somewhere waiting to pounce? Looking forward to more glioblastoma study updates. Good buying opportunity at the moment. Go $iCAD

[anderson800]

So now up to $4.50 per share and my options looking good! But what was the driver yesterday? It went up over 10% on no apparent news. M&A?

I would think that ICAD could be a BO target for either Varian or GE Healthcare.

[anderson800]

Is ICAD a buy at $3.50? Analysts have the company being profitable in 1-2 years. More hospitals are adding the Xoft therapy system. Things may be looking up. I'm grabbing a few Dec options to start. I got the Dec $2.50 calls for $1.30. I'll double my money at about $5 per share.

[tigerpac]

Got out breakeven yesterday due to impending Death Cross at 11.50 .

[Think1st]

Very nice , seems you nailed it!

[tigerpac]

Jumped in at 11.50 this morning after a the stock had a 40% haircut in part due to a revenue and earning miss. The cc transcript showed that the miss was due to longer sales cycle with their enterprise customers rather than a loss of those customers to the competition. Which should mean the sales should eventually happen. Margin expansion as well.

Looking for this stock to retest it's high near 20 in the next 12 months.

[Netcool]

$ICAD

[Netcool]

Gotta like that beautiful ask @ $20. Baby's Got Back!

[whytestocks]

Breaking News: $ICAD iCAD Responds to CMS' Finalized Radiation Oncology Alternative Payment Model

NASHUA, N.H., Sept. 20, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, is providing additional comments following the Centers for Medicare & Medicaid Services’ (CMS) publicat...

Find out more ICAD - iCAD Responds to CMS' Finalized Radiation Oncology Alternative Payment Model

[whytestocks]

JUST IN: $ICAD iCAD's IORT Excluded from CMS's Radiation Oncology Alternative Payment Model

Existing Reimbursement Codes Will Still Apply in All Geographic Markets iCAD Intends to Submit Additional Long-Term Data in Support of IORT’s Inclusion and Petition CMS for Reconsideration NASHUA, N.H., Sept. 18, 2020 (GLOBE NEWSWIRE) -- iCAD , Inc . (NASDAQ: ICAD), a g...

In case you are interested ICAD - iCAD's IORT Excluded from CMS's Radiation Oncology Alternative Payment Model

[Netcool]

Let's get this party started then!

[aintitahoot]

Very quiet board given the recent performance.
New 52 week high & 12 year high, impressive in this market !

[knuts4oe]

Time to rev up this site now that iCAD has broken out in price on volume on a day when all major indices were down!

[whytestocks]

News: $ICAD iCAD Reports Second Quarter 2019 Financial Results

NASHUA, N.H., Aug. 01, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported financial results for the three and six months ended June 30, 2019. Second Quarter 2019 Highlight...

Got this from iCAD Reports Second Quarter 2019 Financial Results

[whytestocks]

News: $ICAD iCAD's ProFound AI(TM) for 2D Mammography Receives CE Mark Approval

NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its advanced artificial intelligence technology and workflow solution, ProFound AI™ for 2D Mammog...

Got this from iCAD's ProFound AI(TM) for 2D Mammography Receives CE Mark Approval

[whytestocks]

News: $ICAD SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence

PHOENIX and NASHUA, N.H., July 10, 2019 (GLOBE NEWSWIRE) -- SimonMed Imaging , one of the largest outpatient medical imaging providers and largest physician radiology practices in the United States, announced today their implementation of the first FDA-cleared AI program for significantl...

Read the whole news SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence

[knuts4oe]

iCAD has yet to be discovered as can be shown by the lack of messages on this board. I predict that they are soon to be discovered as a result of the success of the use of AI in their breast cancer detection software, and by 2020 will be able to give every individual women a personal assessment of their breast cancer odds for the next three years following examination.


This will likely explode the stock price!

[whytestocks]

News: $ICAD iCAD to Highlight ProFound AI(TM) Solution for Digital Breast Tomosynthesis at 2019 Society of Breast Imaging Annual Symposium

NASHUA, N.H., April 04, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will present its latest artificial intelligence software solution for digital breast t...

Find out more https://marketwirenews.com/news-releases/icad-to-highlight-profound-ai-tm-solution-for-digital-breast-tomosynthesis-at-2019-society-of-breast-imaging-annual-symposium-7946588.html

[Alan Brown]

0.8 billion market cap

[TrendTrade2016]

ICAD the big winner for team TREND this week and holding into next.

[TrendTrade2016]

ICAN OMG what a monster!!!

[TrendTrade2016]

ICAD look at this beast fly!!!

[TrendTrade2016]

ICAD booom!!!!!

[TrendTrade2016]

ICAD here we go!!!!

[TrendTrade2016]

AI technology for cancer detection is very interesting. Looking for 5.88 here!

[Craig305]

How much further do you expect this to continue to climb?
Breast cancer is a highly publicized health issue. Any progress will attract great attention here....as what seems to be happening now.

[TrendTrade2016]

ICAD just a beautiful breakout on this bio beast!!!

[TrendTrade2016]

ICAD my next small cap bio play!!

[Netcool]

iCAD - https://www.marketwatch.com/story/icads-stock-soars-after-fda-clearance-of-breast-density-ai-software-product-2018-08-08?link=MW_latest_news

[Netcool]

$ICAD on the rise with imminent submission of FDA approval for PowerLook Tomo Detection 2.0!

https://www.otcmarkets.com/stock/ICAD/news/story?e&id=1081944

[Netcool]

Looking forward to hearing when Powerlook Tomo 2.0 version will be submitted to the FDA.

[blgsmartsta]

I hear that ICAD and SSH are competitors?

I'm not too much familiar with ICAD but I hear that SSH has 5 upgrades and is going through FDA approval right now. I also see a new PR from SSH.

Can you please let me know about ICAD?

[blgsmartsta]

If anyone is interested in a great stock to invest in, they should check out SSH as they've several upgrades and they're working on their FDA approval.

[ospreyeye]

$ICAD Chart - BULLISH HARAMI reversal pattern is forming today - EMA 8 @ 4.11 is the Key level to break -

http://www.candlesticker.com/Pattern.aspx?lang=en&Pattern=2102

BULLISH HARAMI

Definition

This pattern consists of a black body and a small white body that is completely inside the range of the black body. If an outline is drawn for the pattern, it looks like a pregnant woman. This is not a coincidence. “Harami” is an old Japanese word for “pregnant”. The black candlestick is “the mother” and the small candlestick is “the baby”.

[jet1968]

positive moving up lots of room to move 7.13

[Talc Moan]

$1.50 to $11.00+++ What a great Yr for ICAD!

[Talc Moan]

What a beauty she has been.

Smitter SMTT

[Talc Moan]

Yes what a monster.

Smitter SMTT

[Kev2128]

Nice bounces today for ICAD and CVSL huh?

[Talc Moan]

Wow, Lost track of this one awhile back. Always knew they had it in them.

Congrats to Shareholders!!!

Smitter SMTT

[Kev2128]

Looks like this got some good news a couple of days ago smitter!

[mlkrborn]

iCAD Receives FDA Approval for Digital CAD with Philips (PGH) Digital Mammography System (ICAD) 4.71 : Co announced approval by the FDA for use of the company's next generation mammography computer-aided detection (CAD) platform, PowerLook Advanced Mammography Platform (AMP)TM, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.

[Patriot1776]

Great products. Most boring stock ever. Arrgghh. Company has no clue how to tie xoft. Into its marketing strategy.

[mlkrborn]

iCAD Announces distribution agreement with Hitachi (HIT) for MR image analysis and guided biopsy solution (ICAD) 0.71 : Co announced that it has entered into a distribution agreement with Hitachi Medical Systems. With this agreement, iCAD's SpectraLook with PrecisionPoint image analysis solution for breast MRI will be available for purchase with Hitachi's Oasis and Echelon MRI systems. iCAD's MRI solution will assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of MRI studies and streamline the planning and performance of MRI-guided percutaneous breast biopsies.

[Talc Moan]

Watching and waiting to see if she dips below 1.00

Smitter SMTT

[Talc Moan]

As of March 15, 2011, the registrant had 54,421,866 shares of Common Stock outstanding.


Smitter SMTT

[Talc Moan]

Great potential, on Icad

Smitter SMTT

[Talc Moan]

I will do some DD

Smitter SMTT